{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T23:48:59Z","timestamp":1792712939605,"version":"4.5.0"},"reference-count":66,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2014,9,1]],"date-time":"2014-09-01T00:00:00Z","timestamp":1409529600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2014,9,1]],"date-time":"2014-09-01T00:00:00Z","timestamp":1409529600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"crossref","award":["EY13574"],"award-info":[{"award-number":["EY13574"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"crossref","award":["EB00415"],"award-info":[{"award-number":["EB00415"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"crossref","award":["DK35124"],"award-info":[{"award-number":["DK35124"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"crossref","award":["DK72517"],"award-info":[{"award-number":["DK72517"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100008087","name":"Guthy-Jackson Charitable Foundation","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100008087","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Autoimmunity"],"published-print":{"date-parts":[[2014,9]]},"DOI":"10.1016\/j.jaut.2014.02.011","type":"journal-article","created":{"date-parts":[[2014,3,31]],"date-time":"2014-03-31T16:17:24Z","timestamp":1396282644000},"page":"67-77","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":62,"special_numbering":"C","title":["Longitudinally extensive NMO spinal cord pathology produced by passive transfer of NMO-IgG in mice lacking complement inhibitor CD59"],"prefix":"10.1016","volume":"53","author":[{"given":"Hua","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.S.","family":"Verkman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jaut.2014.02.011_bib1","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1038\/ncpneuro0764","article-title":"Mechanisms of disease: aquaporin-4 antibodies in neuromyelitis optica","volume":"4","author":"Jarius","year":"2008","journal-title":"Nat Clin Pract Neurol"},{"key":"10.1016\/j.jaut.2014.02.011_bib2","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1016\/S1474-4422(07)70216-8","article-title":"The spectrum of neuromyelitis optica","volume":"6","author":"Wingerchuk","year":"2007","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.jaut.2014.02.011_bib3","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1038\/nrn3468","article-title":"Aquaporin water channels in the nervous system","volume":"14","author":"Papadopoulos","year":"2013","journal-title":"Nat Rev Neurosci"},{"key":"10.1016\/j.jaut.2014.02.011_bib4","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1038\/nrneurol.2010.72","article-title":"AQP4 antibodies in neuromyelitis optica: diagnostic and pathogenetic relevance","volume":"6","author":"Jarius","year":"2010","journal-title":"Nat Rev Neurol"},{"key":"10.1016\/j.jaut.2014.02.011_bib5","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1084\/jem.20050304","article-title":"IgG marker of optic-spinal multiple sclerosis binds to the aquaporin-4 water channel","volume":"202","author":"Lennon","year":"2005","journal-title":"J\u00a0Exp Med"},{"key":"10.1016\/j.jaut.2014.02.011_bib6","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1016\/S1474-4422(12)70133-3","article-title":"Aquaporin 4 and neuromyelitis optica","volume":"11","author":"Papadopoulos","year":"2012","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.jaut.2014.02.011_bib7","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1007\/s00401-013-1172-z","article-title":"Involvement of antibody-dependent cell-mediated cytotoxicity in inflammatory demyelination in a mouse model of neuromyelitis optica","volume":"126","author":"Ratelade","year":"2013","journal-title":"Acta Neuropathol"},{"key":"10.1016\/j.jaut.2014.02.011_bib8","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.jneuroim.2009.07.014","article-title":"Cytotoxic effect of neuromyelitis optica antibody (NMO-IgG) to astrocytes: an in\u00a0vitro study","volume":"215","author":"Sabater","year":"2009","journal-title":"J\u00a0Neuroimmunol"},{"key":"10.1016\/j.jaut.2014.02.011_bib9","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1177\/1352458506070145","article-title":"Neuromyelitis optica with clinical and histopathological involvement of the brain","volume":"13","author":"Hengstman","year":"2007","journal-title":"Mult Scler"},{"key":"10.1016\/j.jaut.2014.02.011_bib10","doi-asserted-by":"crossref","first-page":"1450","DOI":"10.1093\/brain\/awf151","article-title":"A\u00a0role for humoral mechanisms in the pathogenesis of Devic's neuromyelitis optica","volume":"125","author":"Lucchinetti","year":"2002","journal-title":"Brain"},{"key":"10.1016\/j.jaut.2014.02.011_bib11","doi-asserted-by":"crossref","first-page":"1224","DOI":"10.1093\/brain\/awm047","article-title":"Loss of aquaporin 4 in lesions of neuromyelitis optica: distinction from multiple sclerosis","volume":"130","author":"Misu","year":"2007","journal-title":"Brain"},{"key":"10.1016\/j.jaut.2014.02.011_bib12","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1007\/s00401-013-1116-7","article-title":"Presence of six different lesion types suggests diverse mechanisms of tissue injury in neuromyelitis optica","volume":"125","author":"Misu","year":"2013","journal-title":"Acta Neuropathol"},{"key":"10.1016\/j.jaut.2014.02.011_bib13","doi-asserted-by":"crossref","first-page":"1194","DOI":"10.1093\/brain\/awl371","article-title":"Pattern-specific loss of aquaporin-4 immunoreactivity distinguishes neuromyelitis optica from multiple sclerosis","volume":"130","author":"Roemer","year":"2007","journal-title":"Brain"},{"key":"10.1016\/j.jaut.2014.02.011_bib14","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1002\/ana.22551","article-title":"Ex\u00a0vivo spinal cord slice model of neuromyelitis optica reveals novel immunopathogenic mechanisms","volume":"70","author":"Zhang","year":"2011","journal-title":"Ann Neurol"},{"key":"10.1016\/j.jaut.2014.02.011_bib15","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1093\/brain\/awp309","article-title":"Intra-cerebral injection of neuromyelitis optica immunoglobulin G and human complement produces neuromyelitis optica lesions in mice","volume":"133","author":"Saadoun","year":"2010","journal-title":"Brain"},{"key":"10.1016\/j.jaut.2014.02.011_bib16","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1002\/ana.22686","article-title":"Neutrophil protease inhibition reduces neuromyelitis optica-immunoglobulin G-induced damage in mouse brain","volume":"71","author":"Saadoun","year":"2012","journal-title":"Ann Neurol"},{"key":"10.1016\/j.jaut.2014.02.011_bib17","doi-asserted-by":"crossref","first-page":"2306","DOI":"10.1172\/JCI67554","article-title":"Eosinophil pathogenicity mechanisms and therapeutics in neuromyelitis optica","volume":"123","author":"Zhang","year":"2013","journal-title":"J\u00a0Clin Invest"},{"key":"10.1016\/j.jaut.2014.02.011_bib18","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1016\/S1474-4422(13)70076-0","article-title":"Eculizumab in AQP4-IgG-positive relapsing neuromyelitis optica spectrum disorders: an open-label pilot study","volume":"12","author":"Pittock","year":"2013","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.jaut.2014.02.011_bib19","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1038\/nri2620","article-title":"Complement regulators and inhibitory proteins","volume":"9","author":"Zipfel","year":"2009","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.jaut.2014.02.011_bib20","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1007\/BF02918257","article-title":"Membrane defence against complement lysis: the structure and biological properties of CD59","volume":"12","author":"Davies","year":"1993","journal-title":"Immunol Res"},{"key":"10.1016\/j.jaut.2014.02.011_bib21","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1016\/0169-328X(93)90098-A","article-title":"Expression of CD59, a regulator of the membrane attack complex of complement, on human astrocytes","volume":"18","author":"Gordon","year":"1993","journal-title":"Brain Res Mol Brain Res"},{"key":"10.1016\/j.jaut.2014.02.011_bib22","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1046\/j.1365-2567.1996.d01-637.x","article-title":"Expression and function of membrane regulators of complement on rat astrocytes in culture","volume":"88","author":"Rogers","year":"1996","journal-title":"Immunology"},{"key":"10.1016\/j.jaut.2014.02.011_bib23","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/S0165-5728(96)00136-1","article-title":"Complement expression on astrocytes and astrocytoma cell lines: failure of complement regulation at the C3 level correlates with very low CD55 expression","volume":"71","author":"Spiller","year":"1996","journal-title":"J\u00a0Neuroimmunol"},{"key":"10.1016\/j.jaut.2014.02.011_bib24","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1038\/labinvest.3700015","article-title":"Deficiency of the complement regulator CD59a enhances disease severity, demyelination and axonal injury in murine acute experimental allergic encephalomyelitis","volume":"84","author":"Mead","year":"2004","journal-title":"Lab Invest"},{"key":"10.1016\/j.jaut.2014.02.011_bib25","doi-asserted-by":"crossref","first-page":"3707","DOI":"10.1182\/blood.V99.10.3707","article-title":"Crry, but not CD59 and DAF, is indispensable for murine erythrocyte protection in\u00a0vivo from spontaneous complement attack","volume":"99","author":"Miwa","year":"2002","journal-title":"Blood"},{"key":"10.1016\/j.jaut.2014.02.011_bib26","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.mcn.2007.08.007","article-title":"Aquaporin-4 independent Kir4.1 K+ channel function in brain glial cells","volume":"37","author":"Zhang","year":"2008","journal-title":"Mol Cell Neurosci"},{"key":"10.1016\/j.jaut.2014.02.011_bib27","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1002\/ana.21802","article-title":"Intrathecal pathogenic anti-aquaporin-4 antibodies in early neuromyelitis optica","volume":"66","author":"Bennett","year":"2009","journal-title":"Ann Neurol"},{"key":"10.1016\/j.jaut.2014.02.011_bib28","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1002\/ana.22657","article-title":"Anti-aquaporin-4 monoclonal antibody blocker therapy for neuromyelitis optica","volume":"71","author":"Tradtrantip","year":"2012","journal-title":"Ann Neurol"},{"key":"10.1016\/j.jaut.2014.02.011_bib29","doi-asserted-by":"crossref","first-page":"16516","DOI":"10.1074\/jbc.M111.227298","article-title":"Binding affinity and specificity of neuromyelitis optica autoantibodies to aquaporin-4 M1\/M23 isoforms and orthogonal arrays","volume":"286","author":"Crane","year":"2011","journal-title":"J\u00a0Biol Chem"},{"key":"10.1016\/j.jaut.2014.02.011_bib30","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/0014-2999(80)90515-4","article-title":"Intrathecal morphine in mice: a new technique","volume":"67","author":"Hylden","year":"1980","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.jaut.2014.02.011_bib31","first-page":"1787","article-title":"A\u00a0simple composite phenotype scoring system for evaluating mouse models of cerebellar ataxia","volume":"39","author":"Guyenet","year":"2010","journal-title":"J\u00a0Vis Exp"},{"key":"10.1016\/j.jaut.2014.02.011_bib32","doi-asserted-by":"crossref","first-page":"10865","DOI":"10.1073\/pnas.0805058105","article-title":"TGF-beta signaling in dendritic cells is a prerequisite for the control of autoimmune encephalomyelitis","volume":"105","author":"Laouar","year":"2008","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.jaut.2014.02.011_bib33","doi-asserted-by":"crossref","first-page":"3248","DOI":"10.1523\/JNEUROSCI.19-08-03248.1999","article-title":"Characterization of progressive motor deficits in mice transgenic for the human Huntington's disease mutation","volume":"19","author":"Carter","year":"1999","journal-title":"J\u00a0Neurosci"},{"key":"10.1016\/j.jaut.2014.02.011_bib34","doi-asserted-by":"crossref","first-page":"36068","DOI":"10.1074\/jbc.M306351200","article-title":"Generation of anti-complement \u201cprodrugs\u201d: cleavable reagents for specific delivery of complement regulators to disease sites","volume":"278","author":"Harris","year":"2003","journal-title":"J\u00a0Biol Chem"},{"key":"10.1016\/j.jaut.2014.02.011_bib35","first-page":"33","article-title":"Levels of cell membrane CD59 regulate the extent of complement-mediated lysis of human melanoma cells","volume":"74","author":"Brasoveanu","year":"1996","journal-title":"Lab Invest"},{"key":"10.1016\/j.jaut.2014.02.011_bib36","doi-asserted-by":"crossref","first-page":"7505","DOI":"10.1523\/JNEUROSCI.20-20-07505.2000","article-title":"Deficiency of complement defense protein CD59 may contribute to neurodegeneration in Alzheimer's disease","volume":"20","author":"Yang","year":"2000","journal-title":"J\u00a0Neurosci"},{"key":"10.1016\/j.jaut.2014.02.011_bib37","doi-asserted-by":"crossref","first-page":"1628","DOI":"10.1212\/WNL.0b013e3181c1deb9","article-title":"Pathologic and immunologic profiles of a limited form of neuromyelitis optica with myelitis","volume":"73","author":"Yanagawa","year":"2009","journal-title":"Neurology"},{"key":"10.1016\/j.jaut.2014.02.011_bib38","doi-asserted-by":"crossref","first-page":"3684","DOI":"10.4049\/jimmunol.173.6.3684","article-title":"CD59a is the primary regulator of membrane attack complex assembly in the mouse","volume":"173","author":"Baalasubramanian","year":"2004","journal-title":"J\u00a0Immunol"},{"key":"10.1016\/j.jaut.2014.02.011_bib39","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1016\/j.addr.2011.06.005","article-title":"Complement in health and disease","volume":"63","author":"Carroll","year":"2011","journal-title":"Adv Drug Delivery Rev"},{"key":"10.1016\/j.jaut.2014.02.011_bib40","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1146\/annurev.med.59.060106.185110","article-title":"Complement regulatory genes and hemolytic uremic syndromes","volume":"59","author":"Kavanagh","year":"2008","journal-title":"Annu Rev Med"},{"key":"10.1016\/j.jaut.2014.02.011_bib41","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1136\/jcp.2008.056317","article-title":"Complement deficiency and disease","volume":"61","author":"Unsworth","year":"2008","journal-title":"J\u00a0Clin Pathol"},{"key":"10.1016\/j.jaut.2014.02.011_bib42","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1182\/blood-2012-07-441857","article-title":"CD59 deficiency is associated with chronic hemolysis and childhood relapsing immune-mediated polyneuropathy","volume":"121","author":"Nevo","year":"2013","journal-title":"Blood"},{"key":"10.1016\/j.jaut.2014.02.011_bib43","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1186\/1742-2094-6-2","article-title":"Absence of the complement regulatory molecule CD59a leads to exacerbated neuropathology after traumatic brain injury in mice","volume":"6","author":"Stahel","year":"2009","journal-title":"J\u00a0Neuroinflammation"},{"key":"10.1016\/j.jaut.2014.02.011_bib44","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1186\/1742-2094-7-15","article-title":"Membrane attack complex inhibitor CD59a protects against focal cerebral ischemia in mice","volume":"7","author":"Harhausen","year":"2010","journal-title":"J\u00a0Neuroinflammation"},{"key":"10.1016\/j.jaut.2014.02.011_bib45","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1186\/1742-2094-9-220","article-title":"Deficiency of terminal complement pathway inhibitor promotes neuronal tau pathology and degeneration in mice","volume":"9","author":"Britschgi","year":"2012","journal-title":"J\u00a0Neuroinflammation"},{"key":"10.1016\/j.jaut.2014.02.011_bib46","doi-asserted-by":"crossref","first-page":"4640","DOI":"10.4049\/jimmunol.1201904","article-title":"The alternative complement pathway propagates inflammation and injury in murine ischemic stroke","volume":"189","author":"Elvington","year":"2012","journal-title":"J\u00a0Immunol"},{"key":"10.1016\/j.jaut.2014.02.011_bib47","doi-asserted-by":"crossref","first-page":"3314","DOI":"10.1016\/j.febslet.2013.08.044","article-title":"Hepatitis B virus core protein interacts with CD59 to promote complement-mediated liver inflammation during chronic hepatitis B virus infection","volume":"587","author":"Liu","year":"2013","journal-title":"FEBS Lett"},{"key":"10.1016\/j.jaut.2014.02.011_bib48","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.1038\/nsmb862","article-title":"Human CD59 is a receptor for the cholesterol-dependent cytolysin intermedilysin","volume":"11","author":"Giddings","year":"2004","journal-title":"Nat Struct Mol Biol"},{"key":"10.1016\/j.jaut.2014.02.011_bib49","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1136\/jnnp-2012-302925","article-title":"Distinct genetic and infectious profiles in Japanese neuromyelitis optica patients according to anti-aquaporin 4 antibody status","volume":"84","author":"Yoshimura","year":"2013","journal-title":"J\u00a0Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.jaut.2014.02.011_bib50","doi-asserted-by":"crossref","first-page":"2653","DOI":"10.2337\/diabetes.53.10.2653","article-title":"Glycation inactivation of the complement regulatory protein CD59: a possible role in the pathogenesis of the vascular complications of human diabetes","volume":"53","author":"Qin","year":"2004","journal-title":"Diabetes"},{"key":"10.1016\/j.jaut.2014.02.011_bib51","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1016\/j.jaut.2009.09.013","article-title":"The clinical spectrum and immunobiology of parainfectious neuromyelitis optica (Devic) syndromes","volume":"34","author":"Sellner","year":"2010","journal-title":"J\u00a0Autoimmun"},{"key":"10.1016\/j.jaut.2014.02.011_bib52","doi-asserted-by":"crossref","first-page":"847670","DOI":"10.1155\/2013\/847670","article-title":"Abnormal nerve conduction study findings indicating the existence of peripheral neuropathy in multiple sclerosis and neuromyelitis optica","volume":"2013","author":"Warabi","year":"2013","journal-title":"Biomed Res Int"},{"key":"10.1016\/j.jaut.2014.02.011_bib53","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1016\/S0002-9440(10)64604-4","article-title":"Spontaneous classical pathway activation and deficiency of membrane regulators render human neurons susceptible to complement lysis","volume":"157","author":"Singhrao","year":"2000","journal-title":"Am J Pathol"},{"key":"10.1016\/j.jaut.2014.02.011_bib54","doi-asserted-by":"crossref","first-page":"1592","DOI":"10.1016\/j.molimm.2011.04.003","article-title":"Complement in the brain","volume":"48","author":"Veerhuis","year":"2011","journal-title":"Mol Immunol"},{"key":"10.1016\/j.jaut.2014.02.011_bib55","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1007\/s00401-013-1128-3","article-title":"C1q-targeted monoclonal antibody prevents complement-dependent cytotoxicity and neuropathology in in\u00a0vitro and mouse models of neuromyelitis optica","volume":"125","author":"Phuan","year":"2013","journal-title":"Acta Neuropathol"},{"key":"10.1016\/j.jaut.2014.02.011_bib56","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1046\/j.1365-2249.2000.01305.x","article-title":"Cytokine-mediated up-regulation of CD55 and CD59 protects human hepatoma cells from complement attack","volume":"121","author":"Spiller","year":"2000","journal-title":"Clin Exp Immunol"},{"key":"10.1016\/j.jaut.2014.02.011_bib57","first-page":"167","article-title":"Cytokine-mediated regulation of the surface expression of complement regulatory proteins, CD46 (MCP), CD55 (DAF), and CD59 on human vascular endothelial cells","volume":"12","author":"Moutabarrik","year":"1993","journal-title":"Lymphokine Cytokine Res"},{"key":"10.1016\/j.jaut.2014.02.011_bib58","first-page":"313","article-title":"The effect of glycation of CD59 on complement-mediated cytolysis","volume":"2","author":"Cheng","year":"2005","journal-title":"Cell Mol Immunol"},{"key":"10.1016\/j.jaut.2014.02.011_bib59","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1046\/j.1365-2249.2001.01477.x","article-title":"Involvement of the ERK mitogen-activated protein kinase in cell resistance to complement-mediated lysis","volume":"123","author":"Kraus","year":"2001","journal-title":"Clin Exp Immunol"},{"key":"10.1016\/j.jaut.2014.02.011_bib60","doi-asserted-by":"crossref","first-page":"e21621","DOI":"10.1371\/journal.pone.0021621","article-title":"Soluble CD59 expressed from an adenovirus in\u00a0vivo is a potent inhibitor of complement deposition on murine liver vascular endothelium","volume":"6","author":"Gandhi","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.jaut.2014.02.011_bib61","doi-asserted-by":"crossref","first-page":"e19078","DOI":"10.1371\/journal.pone.0019078","article-title":"A\u00a0non membrane-targeted human soluble CD59 attenuates choroidal neovascularization in a model of age related macular degeneration","volume":"6","author":"Cashman","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.jaut.2014.02.011_bib62","doi-asserted-by":"crossref","first-page":"33826","DOI":"10.1074\/jbc.M110.153130","article-title":"Recombinant membrane-targeted form of CD59 inhibits the growth of choroidal neovascular complex in mice","volume":"285","author":"Bora","year":"2010","journal-title":"J\u00a0Biol Chem"},{"key":"10.1016\/j.jaut.2014.02.011_bib63","doi-asserted-by":"crossref","first-page":"48921","DOI":"10.1074\/jbc.M302598200","article-title":"Generation of a recombinant, membrane-targeted form of the complement regulator CD59: activity in\u00a0vitro and in\u00a0vivo","volume":"278","author":"Fraser","year":"2003","journal-title":"J\u00a0Biol Chem"},{"key":"10.1016\/j.jaut.2014.02.011_bib64","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1113\/jphysiol.1983.sp014822","article-title":"Sites and mechanism of action for the effects of intrathecal noradrenaline on thermoregulation in the rat","volume":"341","author":"LoPachin","year":"1983","journal-title":"J\u00a0Physiol"},{"key":"10.1016\/j.jaut.2014.02.011_bib65","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1016\/j.bbrc.2009.06.085","article-title":"Neuromyelitis optica: passive transfer to rats by human immunoglobulin","volume":"386","author":"Kinoshita","year":"2009","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.jaut.2014.02.011_bib66","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/j.jneuroim.2012.09.010","article-title":"Complement-dependent pathogenicity of brain-specific antibodies in cerebrospinal fluid","volume":"254","author":"Asgari","year":"2013","journal-title":"J\u00a0Neuroimmunol"}],"container-title":["Journal of Autoimmunity"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0896841114000626?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0896841114000626?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,12]],"date-time":"2025-10-12T08:10:11Z","timestamp":1760256611000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0896841114000626"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,9]]},"references-count":66,"alternative-id":["S0896841114000626"],"URL":"https:\/\/doi.org\/10.1016\/j.jaut.2014.02.011","relation":{},"ISSN":["0896-8411"],"issn-type":[{"value":"0896-8411","type":"print"}],"subject":[],"published":{"date-parts":[[2014,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Longitudinally extensive NMO spinal cord pathology produced by passive transfer of NMO-IgG in mice lacking complement inhibitor CD59","name":"articletitle","label":"Article Title"},{"value":"Journal of Autoimmunity","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jaut.2014.02.011","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}